TLDR Semaglutide does not significantly increase the risk of hair loss.
The study investigated the potential link between Semaglutide, a popular weight loss drug, and hair loss. While clinical trials at a higher dose (2.4mg weekly) showed a slight increase in hair loss reports (3% vs. 1% for placebo), real-world data from the Barnes Jewish Healthcare system and the TriNetX database revealed that only 0.80% and 0.83% of patients, respectively, experienced hair loss within six months of starting Semaglutide at 0.25-2mg weekly. These findings suggest that Semaglutide does not significantly increase the risk of hair loss.
1 citations,
March 2023 in “Nutrients” The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.
May 2024 in “Psychiatric News” Weight-loss drugs are not linked to suicidal thoughts.
6 citations,
August 2023 in “Fertility and Sterility” The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.
August 2024 in “Nutrition Bulletin” GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.
6 citations,
August 2023 in “European journal of endocrinology” The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.
